Earnings History Data for Atreca (BCEL) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.


Atreca is a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types. While more traditional oncology drug discovery approaches attempt to generate antibodies against known targets, Atreca?s approach relies on the human immune system to direct it to unique antibody-target pairs from patients experiencing a clinically meaningful, active immune response against their tumors. These unique antibody-target pairs represent a potentially novel and previously unexplored landscape of immuno-oncology targets.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
02-11-2021 PM BCEL Atreca 191.00 -0.74 -0.75 0.00 Atreca EPS in-line
[11/2/2021 9:00 AM]
6.22 -0.07 
6.30 0.01 
4.80 - 20.29 808,243 550,000 13,738
13-05-2021 PM BCEL Atreca, Inc. 372.60 -0.70 -0.65 -0.73 Atreca EPS misses by $0.05
[5/13/2021 8:13 AM]
8.93 -0.89 
9.82 0.0 
8.87 - 25.03 284,892 190,000 9,746
12-08-2020 PM BCEL Atreca, Inc. 376.23 -0.71 -0.77 -3.67 Atreca EPS beats by $0.06
[8/12/2020 8:49 AM]
13.83 0.04 
13.79 0.0 
9.51 - 29.35 341,817 324,829 1,122